MICAL1 Regulates Actin Cytoskeleton Organization, Directional Cell Migration and the Growth of Human Breast Cancer Cells as Orthotopic Xenograft Tumours

MICAL1 gene disruption by CRISPR/Cas9 in MDA MB 231 human breast cancer cells knocked out protein expression, which affected F-actin organization, cell size and motility.